N
Nora Chen
Researcher at University of Melbourne
Publications - 7
Citations - 307
Nora Chen is an academic researcher from University of Melbourne. The author has contributed to research in topics: Appetite & Adipose tissue. The author has an hindex of 6, co-authored 7 publications receiving 287 citations. Previous affiliations of Nora Chen include RMIT University.
Papers
More filters
Journal ArticleDOI
Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet.
Nora Chen,Rebecca Bezzina,Edward Hinch,Paul Lewandowski,David Cameron-Smith,Michael L. Mathai,Markandeya Jois,Andrew J. Sinclair,Denovan P. Begg,Denovan P. Begg,John D. Wark,Harrison S. Weisinger,Richard S. Weisinger +12 more
TL;DR: Novel and separate mechanisms by which tea and EGCG may improve glucose tolerance and support a role for these compounds in obesity prevention are shown.
Journal ArticleDOI
Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats.
Anura P. Jayasooriya,Denovan P. Begg,Denovan P. Begg,Nora Chen,Michael L. Mathai,Andrew J. Sinclair,Jennifer L. Wilkinson-Berka,John D. Wark,Harrison S. Weisinger,Richard S. Weisinger,Richard S. Weisinger +10 more
TL;DR: Given that the elevated blood pressure of the Ren-2 rat is mediated by ANG II, the data suggest that omega-3 PUFA may reduce hypertension via the renin-angiotensin system.
Journal ArticleDOI
Does perinatal ω-3 polyunsaturated fatty acid deficiency increase appetite signaling?
Michael L. Mathai,Mona Soueid,Nora Chen,Nora Chen,Anura P. Jayasooriya,Anura P. Jayasooriya,Andrew J. Sinclair,Mary E. Wlodek,Harrison S. Weisinger,Richard S. Weisinger +9 more
TL;DR: Findings indicate that supply of ω-3 PUFA, particularly during the perinatal period, plays a role in the normal development of mechanisms controlling food intake, especially glucoprivic (i.e. reduced glucose availability) appetite signaling.
Journal ArticleDOI
The problem of obesity: is there a role for antagonists of the renin-angiotensin system?
Richard S. Weisinger,Denovan P. Begg,Nora Chen,Mark Jois,Michael L. Mathai,Andrew J. Sinclair +5 more
TL;DR: The possibility exists that treatment of obesity will be enhanced by the use of natural or synthetic substances that interfere with ANG II, and blocking the production and/or actions of ANG II with drugs or natural substances decreases body fat.
Journal ArticleDOI
The Role of Angiotensin in Obesity and Metabolic Disease
TL;DR: Some of the key evidence from animal and human experiments that links the renin-angiotensin system to obesity and metabolic disease are summarized.